Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Millis, James
One or more keywords matched the following items that are connected to
Millis, James
Item Type
Name
Concept
Muromonab-CD3
Academic Article
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
Academic Article
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
Academic Article
OKT3 escalating dose regimens provide effective therapy for renal allograft rejection.
Academic Article
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
Academic Article
Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Academic Article
Liver transplantation in the first three months of life.
Academic Article
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy.
Academic Article
Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
Academic Article
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.
Academic Article
Living-donor liver transplantation at UCLA.
Academic Article
Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation.
Academic Article
The successful use of repeated courses of OKT3 for hepatic allograft rejection using %T3 cells to adjust dose.
Academic Article
Preservation of renal function using OKT3 in liver transplant patients.
Academic Article
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients.
Search Criteria
Muromonab CD3